Larvol Delta - Arcturus-Therapeutics-Receives-Orphan-Medicinal-Product-Designation-from-the-European-Commission-EC-for-ARCT032-for-the-Treatment-of-Cystic-Fibrosis

ARCT-032 - Arcturus Therap

https://www.businesswire.com/news/home/20240222266344/en/Arcturus-Therapeutics-Receives-Orphan-Medicinal-Product-Designation-from-the-European-Commission-EC-for-ARCT-032-for-the-Treatment-of-Cystic-Fibrosis

Feb 22, 2024

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next